Takashi Owaki

Takashi Owaki

Auto-generated profile, based on publicly available information

Takashi Owaki

Graduate School of Medical and Dental Sciences, Niigata University, Niigata 1 Division of Gastroenterology and Hepatology 951-8510 , Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
MKMasayoshi Ko
Masayoshi Ko
KKKenya Kamimura
Kenya Kamimura
TOTakashi Owaki
Takashi Owaki
TNTakuro Nagoya
Takuro Nagoya
NSNorihiro Sakai
Norihiro Sakai
STShuji Terai
Shuji Terai
The etiology of non-alcoholic fatty liver disease (NAFLD) consists of various factors, including neural signal pathways. However, the molecular mechanisms of the autonomic neural signals influencing NAFLD progression have not been elucidated. Therefore, we examined the involvement of the gut-liver neural axis in NAFLD development and tested the therapeutic effect of modulation of this axis in this study. To test the contribution of the gut-liver neural axis, we examined NAFLD progression with respect to body weight, hepatic steatosis, fibrosis, intestinal tight junction, microbiota and short-chain fatty acids in NAFLD models of choline-deficient defined L-amino-acid and high-fat diet-fed mice with or without blockades of autonomic nerves from the liver. Blockade of the neural signal from the liver to the gut in these NAFLD mice models ameliorated the progression of liver weight, hepatic steatosis and fibrosis by modulating serotonin expression in the small intestine. It was related to the severity of the liver pathology, the tight junction protein expression, microbiota diversity and short-chain fatty acids. These effects were reproduced by administrating serotonin antagonist, which ameliorated the NAFLD progression in the NAFLD mice models. Our study demonstrated that the gut-liver neural axis is involved in the etiologies of NAFLD progression and that serotonin expression through this signaling network is the key factor of this axis. Therefore, modulation of the gut-liver neural axis and serotonin antagonist ameliorates fatty and fibrotic changes in non-alcoholic fatty liver, and can be a potential therapeutic target of NAFLD. This article has an associated First Person interview with the first author of the paper.

30 November 2023 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
MKMasayoshi Ko
Masayoshi Ko
KKKenya Kamimura
Kenya Kamimura
TOTakashi Owaki
Takashi Owaki
TNTakuro Nagoya
Takuro Nagoya
NSNorihiro Sakai
Norihiro Sakai
STShuji Terai
Shuji Terai
There was an error in Dis. Model. Mech. (2021) 14, dmm048922 (doi:10.1242/dmm.048922).An incorrect image was used for Sham+HFD (8W) in Fig. 2B. The original and corrected versions are shown below.The online full text and PDF versions of the paper have been corrected. The authors apologise to readers for this error, which does not impact the results or conclusions of the paper.